论文部分内容阅读
Glioblastoma multiforme(GBM)is the most common malignant primary brain tumor with a survival prognosis of 14-16 mo for the highest functioning patients.Despite aggressive,multimodal upfront therapies,the majority of GBMs will recur in approximately six mo